BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 28, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 17, 2019
View Archived Issues
Preventing drug tolerance to forestall resistance
Read More
New candidate drug for visceral leishmaniasis
Read More
IL-7 receptor plays role in severe IBD
Read More
Wave Life Sciences presents phase I data and updates on development of suvodirsen
Read More
Gilead and insitro enter strategic collaboration to discover and develop new therapies for NASH
Read More
Biomica initiates preclinical studies in immuno-oncology program
Read More
Bromodomain inhibitors reported in Medshine Discovery patent
Read More
Shanghai Synergy Pharmaceutical Sciences, Zhejiang Huahai Pharmaceutical patent JAK inhibitors
Read More
Pohang University of Science and Technology and Seoul National University develop NS5A inhibitors
Read More
Traf3ip3 as a potential new marker of skeletal muscle atrophy
Read More
BP-1003 shows promising activity in PDAC PDX models
Read More
Preclinical characterization of novel anti-VISTA antibody for the treatment of cancer
Read More
Discovery and characterization of a novel BCL6 inhibitor, OICR-10268
Read More
Safety and immunogenicity of ChAdOx1 Chik vaccine in healthy adult volunteers
Read More
RTD-1 shows promising preclinical results in mouse model of cystic fibrosis
Read More
Phase I/IIa trial of antibody-inducing peptide FPP-003 begins in Australia
Read More
Entasis Therapeutics identifies novel series of PBP3 inhibitors for P. aeruginosa infections
Read More
Positive results presented from phase II/III TAZPOWER study of elamipretide
Read More
Otsuka Pharmaceutical initiates two phase III studies of OPA-15406 ointment
Read More
CTT-1403 enters phase I development for metastatic castration-resistant prostate cancer
Read More
Zydus Cadila announces phase III study of desidustat
Read More
"Protein intron" delivers selective antibiotic
Read More
